KRNM.F Stock Overview
Provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Clariane SE Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €4.05 |
| 52 Week High | €4.05 |
| 52 Week Low | €4.05 |
| Beta | 1.06 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -88.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| KRNM.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | -2.8% | 1.8% |
| 1Y | n/a | 3.6% | 24.0% |
Return vs Industry: Insufficient data to determine how KRNM.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how KRNM.F performed against the US Market.
Price Volatility
| KRNM.F volatility | |
|---|---|
| KRNM.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.5% |
| Market Average Movement | 5.7% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: KRNM.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine KRNM.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | n/a | Sophie Boissard | www.clariane.com |
Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom.
Clariane SE Fundamentals Summary
| KRNM.F fundamental statistics | |
|---|---|
| Market cap | US$345.33m |
| Earnings (TTM) | -US$100.21m |
| Revenue (TTM) | US$5.42b |
0.1x
P/S Ratio-3.4x
P/E RatioIs KRNM.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| KRNM.F income statement (TTM) | |
|---|---|
| Revenue | €5.00b |
| Cost of Revenue | €3.43b |
| Gross Profit | €1.57b |
| Other Expenses | €1.66b |
| Earnings | -€92.44m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Aug 05, 2024
| Earnings per share (EPS) | -0.65 |
| Gross Margin | 31.41% |
| Net Profit Margin | -1.85% |
| Debt/Equity Ratio | 115.1% |
How did KRNM.F perform over the long term?
See historical performance and comparison